Building a medtech brand?
We run PR and public affairs for companies in this market: from category launches and funding announcements to NHS procurement and regulatory communications.
Panda Surgical
Handheld neurosurgical robotics
Surgical robotics & devices
UCL spinout building a handheld robotic platform with wristed instruments as small as 3mm, aiming to bring robotic dexterity to brain and spine surgery without a full robotic tower.
The read
Panda Surgical is developing a handheld robotic system with detachable, wristed instruments as small as 3mm in diameter, intended to give more neurosurgeons access to complex brain and spine procedures without the cost and footprint of a full robotic tower. It was founded in 2022 by CEO Manios Dimitrakakis with UCLH neurosurgeon Hani Marcus and UCL professor Danail Stoyanov.
Its NIHR-backed development programme is working toward the first human trial of handheld robotic technology in brain tumour removal surgery, alongside UCL and UCLH. The company is explicit that its system is pre-market and not yet regulator-approved.
The Bridgehead view
Panda Surgical is an early-stage bet, not a proven vendor, and its own site says as much; it is included here as a live example of the UK's next surgical-robotics generation trying to compete on portability and cost rather than matching Intuitive or CMR feature-for-feature.
Work with us
Working across the healthcare sector?
We advise NHS-facing organisations, providers and health systems on reputation, policy engagement and communications that understand the sector.
The firm that knows medtech
We map this sector because
we represent it.
Whether you build medical technology or run the health systems that buy it, we know the market, the media and the regulatory landscape it operates in. Thirty minutes with a partner tells you if we can help.
